Renerve Ltd RNV
Trading Information
- Previous Close Price
- A$0.09
- Day Range
- A$0.08–0.09
- 52-Week Range
- A$0.07–0.22
- Bid/Ask
- A$0.08 / A$0.09
- Shares Outstanding
- 173.50M
- Market Cap
- A$13.88M
- Volume/Avg
- 44,028 / 66,526
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 24.93
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Renerve Ltd specializes in developing a range of ready-to-use products that are cleaner, safer for repairing or replacing damaged peripheral nerves, resulting in good patient outcomes. Its product candidates include NervAlign Bionic Nerve, NervAlign Nerve Graft, and NervAlign Nerve Cuff [The NervAlign Nerve Guide Matrix, The NervAlign Nerve Conduit, The NervAlign Bionic Replacement Nerve]. The company operates in New Zealand and USA generating maximum of revenue is from USA.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- —
- Website
- https://renerve.com.au
Valuation
|
Metric
|
RNV
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 4.34 |
Price/Sales | 24.93 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
RNV
|
|---|---|
Quick Ratio | 2.35 |
Current Ratio | 3.13 |
Interest Coverage | −508.71 |
Quick Ratio
RNV
Profitability
|
Metric
|
RNV
|
|---|---|
Return on Assets (Normalized) | −93.11% |
Return on Equity (Normalized) | −115.52% |
Return on Invested Capital (Normalized) | −114.19% |
Return on Assets
RNV
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|K^R^Ww | LOCK|HF?& | $129B | |||
| Moderna Inc
MRNA
| LOCK|h>!jJ>j | LOCK|YK | $85B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|ZfPh#>M | LOCK|c!>T | $79B | |||
| argenx SE ADR
ARGX
| LOCK|!FR%Vx | LOCK|V$s | $52B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|#%!?%qV | LOCK|Dr& | $41B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|DNp!<Xj | LOCK|Dw?F | $30B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|Hcspn<@ | LOCK|#m&@b | $26B | |||
| BioNTech SE ADR
BNTX
| LOCK|$K#j<Sh | LOCK|&wc | $24B | |||
| Incyte Corp
INCY
| LOCK|l#sDd&% | LOCK|fc | $23B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|S?mr?gn | LOCK|BpM | $14B |
United States